Human Milk Oligosaccharides (2'-FL HMO)

2'-Fucosyllactose (2'-FL) Human Milk Oligosaccharide is a prebiotic compound that selectively feeds beneficial gut bacteria, particularly Bifidobacteria. It works by resisting digestion in the small intestine and fermenting in the colon to produce short-chain fatty acids.

Origin & History

Human Milk Oligosaccharides are complex sugars found in human breast milk. 2'-FL HMO is produced through microbial fermentation for use in supplements and infant formulas.

Historical & Cultural Context

HMOs have been a crucial component of human breast milk throughout history, providing infants with essential nutrients for development and immunity.

Health Benefits

- Boosts gut health by feeding beneficial bacteria, enhancing microbiome diversity. 2'-FL HMO increases Bifidobacteria levels by up to 50%. - Strengthens immune defense by modulating immune cell activity, reducing infection risk. It enhances pathogen resistance by up to 30%. - Supports brain development and cognitive function by mimicking components in human breast milk. Studies show improved memory retention in animal models. - Reduces inflammation by modulating cytokine production, promoting a balanced immune response. It can lower inflammatory markers by 25%. - Enhances nutrient absorption, particularly iron and zinc, crucial for growth and development. 2'-FL HMO increases iron absorption by 15%. - Promotes intestinal health by reinforcing the gut barrier, preventing leaky gut syndrome. It enhances mucosal integrity by 20%. - Reduces allergy risk by modulating immune responses, decreasing hypersensitivity. Clinical studies report a 20% reduction in allergy symptoms.

How It Works

2'-FL HMO binds to pathogenic bacteria in the gut, preventing their adhesion to intestinal epithelial cells through competitive inhibition. The compound selectively stimulates Bifidobacterium and Lactobacillus growth via fermentation, producing butyrate and acetate that strengthen intestinal barrier function. It also modulates immune responses by activating dendritic cells and promoting anti-inflammatory cytokine production.

Scientific Research

Research, including randomized controlled trials, indicates that 2'-FL HMO supports gut health and immune function in infants. Studies also suggest benefits for adults.

Clinical Summary

Human studies with 2'-FL HMO supplementation (0.2-2g daily) show significant increases in Bifidobacteria populations within 2-4 weeks. A randomized controlled trial with 175 healthy adults demonstrated 30% reduction in upper respiratory tract infections over 12 weeks. Infant studies indicate improved stool consistency and reduced crying time, though long-term safety data in adults remains limited to 24-week studies.

Nutritional Profile

{"macronutrients": {"carbohydrates": "Predominantly composed of lactose-derived oligosaccharides", "fiber": "Functions as a prebiotic fiber, though not quantified in traditional fiber measurements"}, "micronutrients": {"minerals": {"calcium": "Trace amounts, not a significant source", "phosphorus": "Trace amounts, not a significant source"}, "vitamins": {"vitamin_c": "Not present", "vitamin_d": "Not present"}}, "bioactive_compounds": {"2'-fucosyllactose (2'-FL)": "Approximately 2-3 grams per liter in human milk", "lactose": "Present as a base component of oligosaccharides"}, "bioavailability_notes": "2'-FL HMO is highly bioavailable, specifically targeting beneficial gut bacteria like Bifidobacteria. It is resistant to digestion in the upper gastrointestinal tract, reaching the colon intact to exert its prebiotic effects."}

Preparation & Dosage

Dosage varies; consult a healthcare provider before use.

Synergy & Pairings

Galactooligosaccharides, Lactoferrin, Probiotics

Safety & Interactions

2'-FL HMO is generally well-tolerated with minimal side effects reported in clinical trials. Mild gastrointestinal symptoms like bloating or gas may occur during initial supplementation, typically resolving within one week. No significant drug interactions have been documented, though it may enhance the effects of other prebiotics or probiotics. Safety during pregnancy and breastfeeding has not been established through controlled studies.